Радионуклидная диагностика для практических врачей - Лишманова Ю.Б.
ISBN 5-93629-166-9
Скачать (прямая ссылка):
119. Kurokawa H., lino K., Kojima H., Saito H. Regional cerebral blood flow in the acute stage with ischemic cerebro-vascular disease studied by xenon-133 inhalation and single photon emission computerised tomography // No To Shinkei. - 1987. - Vol. 39 (5). - P. 437-446.
120. KuwertT, Morgenroth С, Woesler В. et al. Uptake of iodine-123-a-L-methyl tyrosine by gliomas and anon-neoplastic brain lesions// EJNM. -1996.-Vol. 23(10).-P. 1345-1353.
121. Langen К.-J. Evaluation of 1231-a-L-Methyltyrosine as a SPECT tracer of amino acid uptake in brain tumors //SPECT in neurology and psychiatry/Ed. by De Deyn P.P., Dierckx R.A., Alavi A., Pickut B.A. - London: Jonn Libbey&Company Ltd,1997. - P. 387-391.
122. Lassen N.A. 133-Xenon tomography of cerebral blood flow in cerebrovascular disease // Greenhalgh R.M., Rose F.C., eds. Progress in Stroke research 2. - London: Pitman Press, 1983. - P. 197-204.
123. Lassen N.A., Henriksen L., Holm S. Cerebral blood flow tomography. 133-Xenon compared to isopropyl-amphetamine-iodine-123 // J. Nucl. Med. - 1983. - Vol. 24. - P. 17-21.
384
Глава 2. РАДИОНУКЛИДНАЯ ДИАГНОСТИКА В КЛИНИЧЕСКОЙ ПРАКТИКЕ
124. Lassen N.A., Henriksen L., Paulson 0. Regional cerebral blood flow in stroke by 133-Xenon inhalation and emission tomography // Stroke. -1981. - Vol. 12. - P. 284-288.
125. Launes J., Nikkanen P., Lindroth L., Brownell A.-L. Brain perfusion defect size in SPECT predicts outcome in cerebral infarction // Nucl. Med. Commun. - 1989. - Vol. 10. - P. 891-900.
126. Lear J.L. Autoradiographic evaluation of 99m-Tc-hexamethylpropylenamioxime (HMPAO) and TI-201 diethyldithiocarbamate (DDC) as tracers for cerebral blood flow // Nucl. Med. - 1987. - Vol. 26. - P. 32.
127. Lear J.L. Initial cerebral HM-PAO distribution compared to LCBR use of a model which considered cerebral HM-PAO trapping kinetics // J. Cereb. Blood Flow Metab. - 1988. - Vol. 8 (6). - P. 31-37.
128. Lear J.L., Navarro D. Autoradiographic comparison of Thallium-201 diethyldithiocarbamate, isopropyliodoamphetamine and iodoantipyrine as cerebral blood flow tracers//J. Nucl. Med. - 1987. - Vol. 28 (4). - P. 481-486.
129. Lee R.G., Hill T.C., Holman B.L. N-isopropyl-(l-123)-p-iodoamphetamine brain scans with single-photon emission tomography: Discordance with transmission tomography// Radiology. - 1982. - Vol. 145. - P. 795-799.
130. Leinsinger G., Furst H., Schmiedek P., Einhaupl K., Kirsch CM. Cerebrovascular reserve capacity measured with 133-Xenon dynamic SPECT before and after carotid endarterectomy // Schmiedek P., Einhaupl K., Kirsch CM. eds. Stimulated cerebral blood flow. Experimental findings and clinical significance. - Berlin: Springer-Verlag, 1992. - P. 250-256.
131. Leinsinger G., Piepgras A., Einhaupl K. et al. Normal values of cerebrovascular reserve capacity after stimulation with acetazolamide measured by Xenon 133 single-photon emission CT // AJNR. - 1994. - Vol. 15. - P. 1327-1332.
132. Leonard J.P., Nowotnik D.P., Neirihckx R.D. Technetium-99m-d, l-HMPAO: a new radiopharmaceutical for imaging regional brain perfusion using SPECT - a comparison with iodine-123 HIPDM // J. Nucl. Med. - 1986. - Vol. 27 (N.12). - P. 1819-1823.
133. Leveille J., Demonceau G., Walovitch R. Intrasubject comparison between technetium-99m-ECD and Tc-99m-HMPAO in healthy human subjects Il J. Nucl. Med. - 1992. - Vol. 33 (4). - P. 480-484.
134. Limburg M., Hijdra A., de Bruine J.F., Verbeeten B.W.J. RCBF-SPECT in Brain infarction: when does it predict outcome?//J. Nucl. Med. - 1991. - Vol. 32. - P. 382-387.
135. Lingford-Huges A. Psychiatric disorders // M.N. Maisey, K.E. Britton, B.D.Collier (eds). Clinical nuclear medicine. - London: Chapman & Hall Medical, 1998. - P. 319-329.
136. Lingford-Hughes A.R., Pilowsky L.S. In vivo neuroreceptor imaging - methodology and applications in neuropsychiatry syndromes // SPECT in neurology and psychiatry / Ed. by De Deyn PP1 Dierckx R.A., Alavi A., Pickut B.A. - London: Jonn Libbey&Company Ltd,1997. - P. 89-106.
137. Maren Т.Н. Carbonic anhydrase: chemistry, physiology and inhibition // Physion. Rev. - 1967. - Vol. 47. - P. 595-781.
138. Matsuda H., Tsuji S., Shuke N. A quantitative approach to technetium-99m hexamethylpropylene amine oxime // Eur. J. Nucl. Med. - 1992. -Vol. 19(3). - P. 195-200.
139. Matthew R.J., Wilson W.H., Tant S.R. et al. Abnormal resting regional cerebral blood flow patterns and their correlates in schizophrenia//Arch. Gen. Psychiatry. - 1988. - Vol. 45. - P. 542-549.
140. McAfee J.G., Fueger CF1 Stem H.S. etal:Tc-99m pertechnetate for brain imaging//J. Nucl. Med. - 1964. - Vol. 5. - P. 811-827.
141. Messa C, Fazio F1 Costa D.C., Ell P.J. Clinical brain radionuclide Imaging studies //Sem. Nucl. Med. - 1995. - Vol. 25(2). - P. 111-143.
142. Miller B.L., Cummings J.L., Viallanueva-Meyer J. et al. Frontal lobe degeneration: clinical, neuropsychological, and SPECT characteristics // Neurology. - 1991. - Vol. 41. - P. 1374-82.
143. Moore W.S. Surgical significance and management of the ulcerated carotid plaque // Bergan J.J., Yao J.S.T. (ed.). Cerebrovascular insufficiency. - New York: Grune and Stratton, 1983.-P. 199-211.
